Posted by Michael Wonder on 05 Dec 2019
How China’s new drug buying program is causing pain
6 December 2019 - China is overhauling its health-care system with the aim of providing broader access to quality drugs for its enormous population.
The result: drug prices are tumbling and eroding the once-high margins of drug makers, both local and foreign.
For manufacturers, the pressure on prices in the world’s No. 2 pharmaceuticals market is set to intensify as China hones its strategy of extracting mega-discounts in exchange for access.
